Anavex Life Sciences Corp (AVXL)

[williamssc]

One very important factor I think is cost saving which is very important to Medicare and could work in our favor. A pill formula vs Lecanemab outpatient infusion would save thousands of dollars per patient per year. Right now Medicare is struggling to keep costs under control and would welcome an effective prescription Alzheimer's treatment with open arms. Medicare premiums went up because of the high costs associated with Lecanemab.